Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. (NYSE American: XTNT) is a global medical technology company focused on designing, developing, and commercializing orthobiologics and spinal implant fixation systems. The company's website is www.xtantmedical.com. From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Xtant Medical Holdings, Inc. does
In the company’s own words
Xtant Medical Holdings, Inc. (NYSE American: XTNT) is a global medical technology company focused on designing, developing, and commercializing orthobiologics and spinal implant fixation systems. The company's website is www.xtantmedical.com.
The company operates through two primary business segments: orthobiologics products and spinal implant fixation systems. Orthobiologics represent the core business, encompassing demineralized bone matrices, allografts, synthetic bone graft substitutes, and tissue-based products used across trauma, spine, foot and ankle, sports medicine, and wound care applications. Key orthobiologics brands include OsteoSponge, OsteoSelect, OsteoVive Plus, OsteoFactor Pro, the nanOss portfolio, FibreX, Trivium, SimpliGraft, SimpliMax, and CollagenX. The spinal fixation segment includes comprehensive systems for cervical, thoracolumbar, sacroiliac, and interbody applications, with product lines such as Spider Cervical Plating System, Streamline MIS and TL systems, Cortera Posterior Fixation System, Silex Sacroiliac Joint Fusion System, Calix interbody spacers, and Fortilink implants.
Xtant distributes products in the United States through an extensive network of over 670 independent sales agents and stocking agents, supported by direct employees. The company maintains national accounts programs providing access to integrated delivery networks and group purchasing organizations, with contracts from major GPOs including Vizient, Premier, and HealthTrust Purchasing Group. International distribution extends through partners in Europe, Canada, Mexico, South America, and select Pacific region countries.
The company holds ISO 13485 and MDSAP certification and maintains FDA registration as a manufacturer of human cells, tissues, and cellular and tissue-based products. All currently marketed products have received 510(k) clearances or are exempt from FDA premarket review. The biologics patent portfolio includes 46 issued patents expiring between 2028 and 2041, while the fixation portfolio comprises 201 issued patents expiring between 2026 and 2043.
In December 2025, Xtant completed the divestiture of its Coflex and CoFix product assets and its international hardware business through Paradigm Spine GmbH, refocusing operations on core orthobiologics and domestic spinal fixation markets. The company competes with major players including Medtronic, Johnson and Johnson, Bioventus, and Globus Medical, alongside numerous private competitors and tissue banks.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- BELGRADE, MT
- Fiscal year end
- December
- CIK
- 1453593
- SIC
- 3841
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Xtant Medical Holdings, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Xtant Medical Holdings, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Xtant Medical Holdings, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Xtant Medical Holdings, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Xtant Medical Holdings, Inc.'s last four quarterly filings that the numbers alone won't show?”